-
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
08 May 2024 18:40 GMT
… 2024 guidance.
The Details:
Globus Medical reported quarterly earnings of … said Dan Scavilla, CEO of Globus Medical.
Outlook:
The company updated … 63.
Piper Sandler maintained Globus Medical with a Neutral and … Soar On First Post-IPO Q1 Results, Strong Q2 …
-
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
27 Sep 2023 11:00 GMT
… Scavilla, chief executive officer at Globus Medical. “Our support of EUROSPINE … information, please visit the Globus Medical EUROSPINE webpage and the NuVasive … Symposium (IPOS): December 5 to 9 in Orlando.
About Globus Medical, Inc.
Globus Medical is …
-
Globus Medical, Inc. (GMED) CEO Daniel Scavilla on Q2 2022 Results - Earnings Call Transcript
05 Aug 2022 01:23 GMT
… Operator Welcome to the Globus Medical Second Quarter 2022 Earnings … Relations section of the Globus Medical website at www.globusmedical … some of these companies. IPO market has slowed down. … further questions, that concludes Globus Medical's Second Quarter …
-
Who Was Better For The Stock Market? Biden Or Trump?
17 Jan 2025 13:07 GMT
… To Buy And Watch: Top IPOs, Big And Small Caps, Growth … Prices Jump | Stocks To Watch
Globus Medical Stock Revs Up For Next …
-
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
04 Nov 2021 12:37 GMT
… Drug Approval, Kidney Conference, More IPOs In The Pipeline
Chimerix Sinks … . (NASDAQ: COLL) (after the close)
Globus Medical, Inc. (NASDAQ: GMED) (after the … )
IPOs
Hamburg, Germany-based Evotec SE (NASDAQ: EVO) priced its downsized initial public offering …
-
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
30 Jul 2021 12:43 GMT
… NASDAQ: ERAS) (IPOed July 16)
Globus Medical, Inc. (NYSE: GMED)
Horizon … (before the market open)
IPOs
Immuneering Corporation (NASDAQ: IMRX), … dynamics, priced its upsized initial public offering of 7.5 million … , priced its upsized IPO of 13.5 million …
-
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
29 Jul 2021 12:56 GMT
… Lifesciences Corporation (NYSE: EW)
Globus Medical, Inc. (NYSE: GMED)
Horizon … Systems (after the close)
IPOs
Nuvalent, Inc., (NASDAQ: NUVL … in cancer, priced its initial public offering of 9.75 million … diseases, priced its upsized IPO of 12.13 million …
-
BTIG Sees Limited Upside For Globus Medical, Downgrades To Neutral
16 Apr 2018 20:29 GMT
Globus Medical Inc (NYSE: GMED) is up … Ryan Zimmerman downgraded Globus Medical to Neutral.
The Thesis
Globus Medical is seen to … into the price.
Price Action
Globus Medical fell more than 1 percent … Ahead In Biotech: PDUFA Dates, IPOs And More
8 Biotech Stocks …
-
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
22 Apr 2021 12:24 GMT
… better-than-expected quarterly results)
Globus Medical, Inc. (NYSE: GMED)
Integra … close)
IPOs
Mountainview, California-based Neuropace Inc. priced its upsized initial public offering of … different products, priced its upsized IPO of 16.13 million shares …
-
Globus Medical Appoints David M. Demski as CEO
29 Aug 2017 20:15 GMT
… in the Company’s successful initial public offering in 2012. In 2015 … strategy and technology innovation. Globus Medical was built on delivering … is 7826-9364. About Globus Medical, Inc.
Globus Medical, Inc. is a …